JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

Search

Madrigal Pharmaceuticals Inc

Open

SectorHealthcare

416 -0.45

Overview

Share price change

24h

Current

Min

412.15

Max

420.57

Key metrics

By Trading Economics

Income

31M

-42M

Sales

76M

213M

EPS

-1.9

Profit margin

-19.869

Employees

528

EBITDA

31M

-39M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+21.75% upside

Dividends

By Dow Jones

Next Earnings

4 Nov 2025

Market Stats

By TradingEconomics

Market Cap

2.9B

9.8B

Previous open

416.45

Previous close

416

News Sentiment

By Acuity

50%

50%

168 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Madrigal Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Oct 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 Oct 2025, 22:13 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 Oct 2025, 21:20 UTC

Earnings

Correction to IBM 3Q Sales Jump Article

22 Oct 2025, 20:57 UTC

Earnings

SAP Posts Higher 3Q Revenue, Operating Profit

22 Oct 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 Oct 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 Oct 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 Oct 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 Oct 2025, 23:15 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 Oct 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 Oct 2025, 22:02 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 Oct 2025, 21:59 UTC

Acquisitions, Mergers, Takeovers

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 Oct 2025, 21:58 UTC

Acquisitions, Mergers, Takeovers

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 Oct 2025, 21:57 UTC

Acquisitions, Mergers, Takeovers

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 Oct 2025, 21:56 UTC

Acquisitions, Mergers, Takeovers

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 Oct 2025, 21:47 UTC

Acquisitions, Mergers, Takeovers

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 Oct 2025, 21:47 UTC

Earnings

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 Oct 2025, 21:47 UTC

Acquisitions, Mergers, Takeovers

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 Oct 2025, 21:46 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 Oct 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 Oct 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 Oct 2025, 21:28 UTC

Market Talk
Earnings

Correction to Alcoa Tariff Market Talk

22 Oct 2025, 21:25 UTC

Earnings

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 Oct 2025, 21:17 UTC

Earnings

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 Oct 2025, 21:09 UTC

Market Talk
Earnings

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 Oct 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22 Oct 2025, 20:59 UTC

Earnings

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 Oct 2025, 20:51 UTC

Earnings

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 Oct 2025, 20:44 UTC

Earnings

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

21.75% upside

12 Months Forecast

Average 506.43 USD  21.75%

High 590 USD

Low 266 USD

Based on 16 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

14

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

263.2 / 277.1Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Neutral Evidence

Sentiment

By Acuity

168 / 371 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
help-icon Live chat